Simcere Pharma initiates up to RMB 1.00 billion share buyback, covering 10% of issued capital

Bulletin Express

Aug 20

Simcere Pharmaceutical Group Limited (Simcere Pharma) has announced a voluntary share repurchase plan of up to RMB 1.00 billion, utilising a general mandate approved by shareholders on 12 June 2026. The mandate authorises the company to buy back as many as 256.82 million shares, equivalent to 10% of the total shares outstanding on the approval date.

The board resolved on 20 August 2026 to execute the repurchases in the open market from 21 August 2026 until the earliest of: (a) the next annual general meeting, (b) the deadline for holding the next annual general meeting under the company’s articles or applicable law, or (c) any earlier revocation or variation of the mandate by shareholders.

Funding for the programme will be drawn solely from internal resources. The board stated that the initiative is intended to signal confidence in Simcere Pharma’s business outlook while maintaining a solid financial position. Repurchases will comply with the company’s articles of association, the Hong Kong Listing Rules and all other relevant regulations.

Execution of the buyback will depend on market conditions and remains at the board’s discretion. Shareholders and potential investors are advised to exercise caution when dealing in the company’s shares.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://au1.tigerplaytime.com/news/1183742507"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1183742507\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1183742507?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-20 23:06","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1183742507","market":"hk","top_or_hot":-1,"title":"Simcere Pharma initiates up to RMB 1.00 billion share buyback, covering 10% of issued capital","media":"Bulletin Express","content":"<p>Simcere Pharmaceutical Group Limited (Simcere Pharma) has announced a voluntary share repurchase plan of up to RMB 1.00 billion, utilising a general mandate approved by shareholders on 12 June 2026. The mandate authorises the company to buy back as many as 256.82 million shares, equivalent to 10% of the total shares outstanding on the approval date.</p>\n<p>The board resolved on 20 August 2026 to execute the repurchases in the open market from 21 August 2026 until the earliest of: (a) the next annual general meeting, (b) the deadline for holding the next annual general meeting under the company’s articles or applicable law, or (c) any earlier revocation or variation of the mandate by shareholders.</p>\n<p>Funding for the programme will be drawn solely from internal resources. The board stated that the initiative is intended to signal confidence in Simcere Pharma’s business outlook while maintaining a solid financial position. Repurchases will comply with the company’s articles of association, the Hong Kong Listing Rules and all other relevant regulations.</p>\n<p>Execution of the buyback will depend on market conditions and remains at the board’s discretion. Shareholders and potential investors are advised to exercise caution when dealing in the company’s shares.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Simcere Pharma initiates up to RMB 1.00 billion share buyback, covering 10% of issued capital</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSimcere Pharma initiates up to RMB 1.00 billion share buyback, covering 10% of issued capital\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-08-20 23:06</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Simcere Pharmaceutical Group Limited (Simcere Pharma) has announced a voluntary share repurchase plan of up to RMB 1.00 billion, utilising a general mandate approved by shareholders on 12 June 2026. The mandate authorises the company to buy back as many as 256.82 million shares, equivalent to 10% of the total shares outstanding on the approval date.</p>\n<p>The board resolved on 20 August 2026 to execute the repurchases in the open market from 21 August 2026 until the earliest of: (a) the next annual general meeting, (b) the deadline for holding the next annual general meeting under the company’s articles or applicable law, or (c) any earlier revocation or variation of the mandate by shareholders.</p>\n<p>Funding for the programme will be drawn solely from internal resources. The board stated that the initiative is intended to signal confidence in Simcere Pharma’s business outlook while maintaining a solid financial position. Repurchases will comply with the company’s articles of association, the Hong Kong Listing Rules and all other relevant regulations.</p>\n<p>Execution of the buyback will depend on market conditions and remains at the board’s discretion. Shareholders and potential investors are advised to exercise caution when dealing in the company’s shares.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02096","symbol_name":"先声药业","start_time":0,"source_url":"","article_id":"1183742507","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1183742507","pubTimestamp":1787238377,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Simcere Pharmaceutical Group Limited (Simcere Pharma) has announced a voluntary share repurchase plan of up to RMB 1.00 billion, utilising a general mandate approved by shareholders on 12 June 2026....","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02096":"先声药业"},"translate_title":"先声医药发起最高10亿元人民币股份回购，占已发行股本的10%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02096":1},"content_text":"Simcere Pharmaceutical Group Limited (Simcere Pharma) has announced a voluntary share repurchase plan of up to RMB 1.00 billion, utilising a general mandate approved by shareholders on 12 June 2026. The mandate authorises the company to buy back as many as 256.82 million shares, equivalent to 10% of the total shares outstanding on the approval date.\nThe board resolved on 20 August 2026 to execute the repurchases in the open market from 21 August 2026 until the earliest of: (a) the next annual general meeting, (b) the deadline for holding the next annual general meeting under the company’s articles or applicable law, or (c) any earlier revocation or variation of the mandate by shareholders.\nFunding for the programme will be drawn solely from internal resources. The board stated that the initiative is intended to signal confidence in Simcere Pharma’s business outlook while maintaining a solid financial position. Repurchases will comply with the company’s articles of association, the Hong Kong Listing Rules and all other relevant regulations.\nExecution of the buyback will depend on market conditions and remains at the board’s discretion. Shareholders and potential investors are advised to exercise caution when dealing in the company’s shares.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding,buyback,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}